Purple Biotech (PPBT) Acquisitions (2023)
Purple Biotech (PPBT) reported Acquisitions of $3.5 million for Q4 2023, up 199.9% quarter-over-quarter from -$3.5 million in Q1 2023.
Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends
Purple Biotech (PPBT) has 1 years of Acquisitions data on file, last reported at $3.5 million in Q4 2023.
- Acquisitions for Q4 2023 came in at $3.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was -$3549.0 (changed N/A YoY), and the FY2023 annual result was -$3549.0, changed N/A from the prior year.
- Acquisitions improved to $3.5 million in Q4 2023 per PPBT's latest filing, from -$3.5 million in the prior quarter.
- Over five years, Acquisitions peaked at $3.5 million in Q4 2023 and troughed at -$3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.55 Mn |
| Mar 31, 2023 | -3.55 Mn |